| A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus … BH Rovin, N Solomons, WF Pendergraft III, MA Dooley, J Tumlin, ... Kidney international 95 (1), 219-231, 2019 | 313 | 2019 |
| Nephropathy in diabetes B Satirapoj Diabetes: An Old Disease, a New Insight, 107-122, 2012 | 154 | 2012 |
| Tubulointerstitial biomarkers for diabetic nephropathy B Satirapoj Journal of diabetes research 2018 (1), 2852398, 2018 | 138 | 2018 |
| Comprehensive approach to diabetic nephropathy B Satirapoj, SG Adler Kidney research and clinical practice 33 (3), 121-131, 2014 | 126 | 2014 |
| Review on pathophysiology and treatment of diabetic kidney disease B Satirapoj J Med Assoc Thai 93 (Suppl 6), S228-41, 2010 | 91 | 2010 |
| Prevalence and management of diabetic nephropathy in western countries B Satirapoj, SG Adler Kidney diseases 1 (1), 61-70, 2015 | 86 | 2015 |
| Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells B Satirapoj, Y Wang, MP Chamberlin, T Dai, J LaPage, L Phillips, ... Nephrology Dialysis Transplantation 27 (7), 2702-2711, 2012 | 85 | 2012 |
| Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus B Satirapoj, S Tassanasorn, M Charoenpitakchai, O Supasyndh PLoS One 10 (4), e0124055, 2015 | 82 | 2015 |
| Exertional heatstroke: early recognition and outcome with aggressive combined cooling—a 12-year experience P Sithinamsuwan, K Piyavechviratana, T Kitthaweesin, W Chusri, ... Military medicine 174 (5), 496-502, 2009 | 82 | 2009 |
| Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population B Satirapoj, P Limwannata, A Chaiprasert, O Supasyndh, P Choovichian BMC nephrology 14, 1-5, 2013 | 79 | 2013 |
| Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic … B Satirapoj, R Dispan, P Radinahamed, C Kitiyakara BMC nephrology 19, 1-10, 2018 | 75 | 2018 |
| Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients O Supasyndh, B Satirapoj, P Aramwit, D Viroonudomphol, A Chaiprasert, ... Clinical Journal of the American Society of Nephrology 8 (2), 271-279, 2013 | 67 | 2013 |
| Relationship between serum uric acid levels with chronic kidney disease in a Southeast Asian population B Satirapoj, O Supasyndh, A Chaiprasert, P Ruangkanchanasetr, ... Nephrology 15 (2), 253-258, 2010 | 65 | 2010 |
| Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke B Satirapoj, S Kongthaworn, P Choovichian, O Supasyndh BMC nephrology 17, 1-6, 2016 | 57 | 2016 |
| Safety and efficacy of long‐term Voclosporin treatment for lupus nephritis in the phase 3 AURORA 2 clinical trial A Saxena, EM Ginzler, K Gibson, B Satirapoj, AEZ Santillán, O Levchenko, ... Arthritis & Rheumatology 76 (1), 59-67, 2024 | 56 | 2024 |
| Novel insights into the relationship between glomerular pathology and progressive kidney disease B Satirapoj, CC Nast, SG Adler Advances in chronic kidney disease 19 (2), 93-100, 2012 | 56 | 2012 |
| Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients P Wantanasiri, B Satirapoj, M Charoenpitakchai, P Aramwit Lupus 24 (8), 835-845, 2015 | 54 | 2015 |
| Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: a prospective cohort study B Satirapoj, P Pooluea, N Nata, O Supasyndh Journal of Diabetes and its Complications 33 (9), 675-681, 2019 | 44 | 2019 |
| Urine periostin as a biomarker of renal injury in chronic allograft nephropathy B Satirapoj, R Witoon, P Ruangkanchanasetr, P Wantanasiri, ... Transplantation proceedings 46 (1), 135-140, 2014 | 43 | 2014 |
| Sodium-glucose cotransporter 2 inhibitors with renoprotective effects B Satirapoj Kidney Diseases 3 (1), 24-32, 2017 | 42 | 2017 |
Ouppatham SupasyndhPhramongkutklao Hospital and College of MedicineVerified email at pcm.ac.th